BTAX — Biostax Balance Sheet
0.000.00%
- $0.02m
- $1.51m
Annual balance sheet for Biostax, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-Q |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 0.005 | 0.01 | 3.14 | 0.15 | 0.03 |
Total Inventory | |||||
Total Current Assets | 0.005 | 0.01 | 3.14 | 0.15 | 0.03 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.001 | 0 | — | — | — |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 0.006 | 0.01 | 3.14 | 0.964 | 0.035 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 13.7 | 11.7 | 11.1 | 3.48 | 4.56 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 13.7 | 11.7 | 11.1 | 3.48 | 4.56 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -13.7 | -11.7 | -7.95 | -2.51 | -4.53 |
Total Liabilities & Shareholders' Equity | 0.006 | 0.01 | 3.14 | 0.964 | 0.035 |
Total Common Shares Outstanding |